Tags

Type your tag names separated by a space and hit enter

Challenges in evaluating SARS-CoV-2 vaccines during the COVID-19 pandemic.
CMAJ. 2020 08 24; 192(34):E982-E985.CMAJ

Links

PMC Free PDF

Authors+Show Affiliations

Abu-Raya B
Vaccine Evaluation Center, BC Children's Hospital Research Institute, and Division of Infectious Diseases, Department of Pediatrics, University of British Columbia, Vancouver, BC baburaya@bcchr.ubc.ca.
Gantt S
Vaccine Evaluation Center, BC Children's Hospital Research Institute, and Division of Infectious Diseases, Department of Pediatrics, University of British Columbia, Vancouver, BC.
Sadarangani M
Vaccine Evaluation Center, BC Children's Hospital Research Institute, and Division of Infectious Diseases, Department of Pediatrics, University of British Columbia, Vancouver, BC.

MeSH

BetacoronavirusCOVID-19COVID-19 VaccinesCommunicable Disease ControlCoronavirus InfectionsDrug DevelopmentHumansPandemicsPneumonia, ViralSARS-CoV-2Viral Vaccines

Pub Type(s)

Journal Article
Research Support, Non-U.S. Gov't

Language

eng

PubMed ID

32646869

Citation

Abu-Raya, Bahaa, et al. "Challenges in Evaluating SARS-CoV-2 Vaccines During the COVID-19 Pandemic." CMAJ : Canadian Medical Association Journal = Journal De l'Association Medicale Canadienne, vol. 192, no. 34, 2020, pp. E982-E985.
Abu-Raya B, Gantt S, Sadarangani M. Challenges in evaluating SARS-CoV-2 vaccines during the COVID-19 pandemic. CMAJ. 2020;192(34):E982-E985.
Abu-Raya, B., Gantt, S., & Sadarangani, M. (2020). Challenges in evaluating SARS-CoV-2 vaccines during the COVID-19 pandemic. CMAJ : Canadian Medical Association Journal = Journal De l'Association Medicale Canadienne, 192(34), E982-E985. https://doi.org/10.1503/cmaj.201237
Abu-Raya B, Gantt S, Sadarangani M. Challenges in Evaluating SARS-CoV-2 Vaccines During the COVID-19 Pandemic. CMAJ. 2020 08 24;192(34):E982-E985. PubMed PMID: 32646869.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Challenges in evaluating SARS-CoV-2 vaccines during the COVID-19 pandemic. AU - Abu-Raya,Bahaa, AU - Gantt,Soren, AU - Sadarangani,Manish, Y1 - 2020/07/09/ PY - 2020/7/11/pubmed PY - 2020/9/4/medline PY - 2020/7/11/entrez SP - E982 EP - E985 JF - CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne JO - CMAJ VL - 192 IS - 34 SN - 1488-2329 UR - https://www.unboundmedicine.com/medline/citation/32646869/Challenges_in_evaluating_SARS_CoV_2_vaccines_during_the_COVID_19_pandemic_ DB - PRIME DP - Unbound Medicine ER -